Wednesday, October 27, 2021

William Gruber, Pfizer’s senior vice president for vaccine clinical research and development

 COVID vaccines to be required for military under new US plan
August 9, 2021
…………………………………….......................
Tracking the FDA advisory panel meeting on Covid-19 vaccines for kids      Oct. 26, 2021
  The moment some parents have been anxiously awaiting for months is almost here:  The Pfizer-BioNTech Covid-19 vaccine for children aged 5 to 11 will likely be authorized for use in the next week, after completion of a four-step process that begins today….
  William Gruber, Pfizer’s senior vice president for vaccine clinical research and development, appeared to acknowledge the dosing schedule may need work. But he said when the vaccine was being developed and tested the pandemic was raging and the goal was to protect people as quickly as possible.  “Obviously as we think farther ahead to a post-pandemic period, and particularly as we get into very younger populations it may be advisable … particularly in that first year of life to look at longer intervals as part of a routine immunization series,” Gruber said. “But we don’t have that data now.”  https://www.statnews.com/2021/10/26/pfizer-covid19-vaccine-kids-vrbpac-fda/
……………………………......................................…
  Dr. Gruber is Senior Vice President of Pfizer Vaccine Clinical Research and Development, and is responsible for global clinical development of vaccines.  He joined in 1999 as Vice President of Clinical Vaccine Research for Wyeth, now a wholly owned subsidiary of Pfizer. Prior to his position at Wyeth Dr. Gruber was an Associate Professor of Pediatrics in the Division of Pediatric Infectious Diseases, Vanderbilt University School of Medicine.  He also served as the Director of the Diagnostic Virology Laboratory at Vanderbilt University Hospital.
 Dr. Gruber has served as a consultant reviewer for the National Institutes of Health, NIAID,

                         -Dr. William Gruber and Bill Gates
the Bill and Melinda Gates Foundation, and PATH. 
Dr. Gruber received his bachelor degree in Mathematical Sciences from Rice University, Houston, Texas, and his medical degree from Baylor College of Medicine, Houston, Texas.  He received his pediatric and infectious disease training at Baylor College of Medicine where he also served as Chief Resident in Pediatrics.
During his industry career Dr. Gruber’s clinical research group has been responsible for global clinical development of pneumococcal conjugate, meningococcal conjugate, rLP2086 meningococcal B, Staph aureus, C. difficile, HIV, influenza, RSV, parainfluenza, and HSV vaccines.  Dr Gruber is responsible for guiding clinical research direction for Pfizer’s Group B streptococcus, CMV and RSV maternal and adolescent vaccine programs.   https://www.pfizer.com/people/medical-experts/vaccinations/william_gruber-md-faap-fidsa-0
……………………………………….
At 5:20 of video:  Now you might not realize that the rich elite buying up the land (like Bill Gates buying up alot of American farmland), and specifically the farmland, falls right into the World Economic Forum’s Agenda for 2030.  Now it’s kind of ironic that while billionaires are acquiring the land they appear to be telling us that in the future private property is virtually going to cease to exist.  World Economic Forum founder Klaus Schwab made it clear in his 2 books 4th Revolution and Covid-19, the Great Reset :will lead to the abolition of private property.”…Instead (in 2030) you wil be dependent on a small number of elitists who own everything.  
-Mark Moss   https://video.search.yahoo.com/search/video?fr=yfp-t&ei=UTF-8&p=bill+gates+kissinger#id=51&vid=869435f03b941c508a0c899aec551ec8&action=view
…………………….............................................
             -Bill Gates and Kissinger

................................................................................




Mar 9, 2021  https://twitter.com/johnthespinner1/status/1369303614938902535
……………...................................................

                          - Gates and Schwab

No comments:

Post a Comment